Optimal Lymph Flow for Lymphedema

MR
SK
Overseen ByStephanie Korth, APRN
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Missouri, Kansas City
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

Lymphatic pain refers to various pain sensations (e.g., pain, aching, soreness, tenderness, burning, stabbing) following breast cancer treatment. Lymphatic pain affects more than half of 4 million patients treated for breast cancer in the United States. Lymphatic pain significantly impairs patients' daily living function, increases psychological distress, and decreases quality of life. As a significant risk of lymphedema, lymphatic pain indicates an early stage of lymphedema. Lymphedema is a chronic and incurable swelling caused by an abnormal fluid build-up following breast cancer treatment. Without timely intervention in this early stage, lymphedema can progress into a chronic condition that no surgical or medical interventions can cure.

The purpose of the project is to adapt The-Optimal-Lymph-Flow (TOLF) in clinical practice. A digital lymphatic pain and lymphedema assessment will be implemented in clinical practice, conduct clinician training and deliver TOLF Self-Care interventions to patients with lymphatic pain.

Who Is on the Research Team?

MR

Mei Rosemary Fu, PhD

Principal Investigator

University of Missouri, Kansas City

Are You a Good Fit for This Trial?

This trial is for people who have had breast cancer treatment and are experiencing lymphatic pain or swelling in the arm, which may be an early sign of lymphedema. Participants should be able to use digital tools and follow self-care instructions.

Inclusion Criteria

I am over 18 and had breast cancer surgery more than 3 months ago.
I have experienced pain in my lymph nodes.
I can understand and follow instructions in English.

Exclusion Criteria

Presence of a serious psychiatric condition (e.g., schizophrenia, suicidal intent) indicated by medical chart, treating oncologist or other staff, or study staff interactions that would contraindicate safe study participation
I have cancer that has spread, come back, or caused swelling, or is in my chest or neck.

What Are the Treatments Tested in This Trial?

Interventions

  • The-Optimal-Lymph-Flow

Trial Overview

The study tests a program called The-Optimal-Lymph-Flow (TOLF), which includes digital assessments, clinician training, and teaching patients self-care techniques to manage lymphatic pain and prevent worsening swelling after breast cancer treatment.

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: The-Optimal-Lymph-FlowExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Missouri, Kansas City

Lead Sponsor

Trials
73
Recruited
34,600+